Global X China Biotech Innovation ETF Aggregate Rating and Price Target (2024)
MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.
Holdings in CHB have an aggregate rating of Buy based on 5 analyst ratings issued in the past year covering 1 companies (4.1% of the portfolio).
| High Prediction | $30.61 |
|---|
| Average Prediction | $26.80 |
|---|
| Low Prediction | $19.82 |
|---|
Holdings in CHB have an aggregate price target of $26.80 and a range of $19.82 to $30.61 covering 1 companies (4.1% of the portfolio).
| Strong Buy | |
|---|
| Buy | |
|---|
| Moderate Buy | |
|---|
| Hold | |
|---|
| Reduce | |
|---|
| Sell | |
|---|
| Strong Sell | |
|---|
Ratings for Stocks Held by Global X China Biotech Innovation ETF
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy
Ratings for the Top 1 CHB Holdings
